News

Fintel on MSN1d
Canaccord Genuity Initiates Coverage of Celldex Therapeutics (CLDX) with Buy Recommendation
Fintel reports that on April 28, 2025, Canaccord Genuity initiated coverage of Celldex Therapeutics (NasdaqCM:CLDX) with a ...
Parkit Enterprise (PKTEF) Receives a Buy from Canaccord Genuity
Canaccord Genuity analyst Mark Rothschild maintained a Buy rating on Parkit Enterprise (PKTEF – Research Report) yesterday and set a price ...
Investment Bank Meaningfully Raises Price Target on ServiceNow (NOW) Stock
Investment bank Canaccord Genuity today increased its price target on ServiceNow (NOW) stock to $1,075 from $900 after the ...
FRESNILLO (FNLPF) Gets a Hold from Canaccord Genuity
Canaccord Genuity analyst Tim Huff reiterated a Hold rating on FRESNILLO (FNLPF – Research Report) today and set a price target of p980.00. The ...